Cancer Risk Assessment

Cancer Risk Assessment Cancer Risk Assessment is a provider of OncoVue, the new genetic-based breast cancer risk assessment test.

OncoVue is a powerful tool to assess a woman's genetic risk for breast cancer. The OncoVue® breast cancer risk test is a result of research focused on understanding the role that multiple single nucleotide polymorphisms (SNPs) along with personal history measures contribute to a woman’s risk of developing breast cancer at various stages in her life. Oncovue is a simple saliva test covered by most insurance plans.

Address

New York, NY
10019

Alerts

Be the first to know and let us send you an email when Cancer Risk Assessment posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share